RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Frontiers in Pharmacology

Topics

Chemistry

Biochemistry

Medicine

Immunology

Internal Medicine

Show all topics

DOI

10.3389/fphar.2024.1426446

License

CC-BY

Other Formats

PDF